<DOC>
	<DOCNO>NCT00079599</DOCNO>
	<brief_summary>Patients AIDS may develop deficiency micronutrient carnitine deficiency may contribute fatigue patient . This study determine whether carnitine supplementation improve fatigue relate symptom carnitine-deficient patient AIDS .</brief_summary>
	<brief_title>L-Carnitine Treat Fatigue AIDS Patients</brief_title>
	<detailed_description>Fatigue commonly report symptom patient end stage AIDS . Appropriate treatment relieve suffer improve quality life . The role progression disease , depression , anemia , poor nutritional status development fatigue well recognize . However , impact micronutrient deficiency minimally explore . AIDS patient risk micronutrient deficiency decrease caloric intake , increase metabolic requirement , treatment medication interfere absorption , synthesis , excretion . Patients AIDS particularly likely carnitine deficient . Levocarnitine ( L-carnitine ) micronutrient find meat dairy product play major role energy metabolism . Preliminary research show patient end stage AIDS experience decreased level fatigue L-carnitine supplementation . This study evaluate effectiveness L-carnitine treat patient carnitine deficiency , fatigue , AIDS . Participants study randomly assign receive either L-carnitine placebo 2 week . To reduce possibility side effect , dose L-carnitine placebo titrate 6 day desire study dose . After 2 week , participant receive placebo switch receive L-carnitine . All participant continue L-carnitine additional 2 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<criteria>AIDS Stage IVC estimate life expectancy &lt; 6 month Karnofsky Performance Score &gt; 50 Clinically significant , persistent fatigue If undergoing preexist treatment fatigue , must stable regimen least 4 week prior study entry Concurrent use epoetin alfa ( PROCRITÂ® ) allow patient stable dose epoetin alfa least 60 day prior study entry Severe cardiovascular , pulmonary , renal function Hemodialysis Treatment replacement therapy form carnitine within 12 month prior study entry Known sensitivity carnitine Acute illness within 30 day study entry opinion study investigator would interfere participation Active drug alcohol use dependence History central nervous system disease involve brain may put patient risk seizure ( e.g. , primary metastatic brain tumor , stroke ) history seizure History dementia , aphasia , deficit cognition speech/language function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Carnitine Deficiency</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Complementary Therapies</keyword>
</DOC>